Innovative Medicines Initiative 2 funding opportunities

The Innovative Medicines Initiative (IMI) has now launched its 18th and 19th Calls for proposals under IMI2. The Call gives researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future. 

Why apply? 

• Obtain research funding
• Take part in scientifically excellent, patient-centric research
• Join unique consortia involving top teams from industry, academia, SMEs, regulators, and others
• Benefit from the expertise, databases, and infrastructures of consortium partners
• Boost the visibility and status of your organisation in Europe and globally and gain access to new markets
   

IMI2 – Call 18

IMI2 – Call 18 was launched on 26 June 2019 and is a standard, two-stage Call for proposals. It includes the following topics:  

• Central repository of digital pathology slides to support the development of artificial intelligence tools
• Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardised manner creating transparency of health outcomes
• Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project
• Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
• Accelerating research & innovation for advanced therapy medicinal products
• Supporting the development of engineered T cells
   

IMI2 – Call 19 

IMI2 - Call19 is a single stage restricted Call for proposals designed to support further research activities to allow existing successful IMI consortia to build on the achievements of their initial action, move onto the next step of the research challenge, and maximise the impacts of the initial action results. As such the Call is restricted to the initial consortia of actions that fulfil the following two conditions: 

• funded through topics launched under Calls for proposals in 2014 and of 2015, since only these actions are sufficiently advanced in their implementation to be considered for follow-up research activities;
• derived from topics where the topic text already informed potential applicants about the possibility of a later restricted Call.

In practice, the consortia that meet these criteria are: ADAPT-SMART, BEAt-DKD, DO-IT, HARMONY, INNODIA, ITCC-P4, MOPEAD, NGN-PET, PRISM, RADAR-CNS, RESCEU, RHAPSODY, TransQST. 

How to apply

• The rules and details of how to apply can be found via the Call pages of the IMI website.
• Find out more about both Calls for proposals via our webinars – see bit.ly/2W8RhBu
• Follow IMI’s tips for applicants – see bit.ly/IMItips
• Get advice on finding project partners on our partner search page –  bit.ly/IMIfindpartners